Enriched bone marrow-derived progenitor cells for ischemic diseases
The aim of this trial is to investigate whether intraarterial infusion of autologous progenitor cells can improve organ perfusion. Bone marrow-derived progenitor cells are used to treat critical limb ischemia. Treatment proved safe and feasible and accelerated ulcer healing and pain reduction in patients with stable ulcers or rest pain.
Read More
Product Information for
Enriched bone marrow-derived progenitor cells for ischemic diseases